In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...
Aberdeen Proving Ground, Md. – Researchers at the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) have begun the process of creating a mannikin capable of ...
April 10 (Reuters) - The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant ...
The Pentagon’s proposed 2026 fiscal year budget comes in at more than one trillion dollars, and $179 billion of that is just for research, development, testing, and evaluation. That money doesn’t go ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
REDSTONE ARSENAL, Ala. (May 6, 2022) – When it comes to the nation’s defense and protection of the Warfighter, the U.S. Army Combat Capabilities Development Command Aviation & Missile Center’s ...
Horses are just as much a part of New Mexico’s story as green chile and balloons. One local startup is hoping their research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results